NanoBurstX™, developed by I 2 Air Fluid Innovation, Inc., uses Chemically Initiated Nanobubble (CINB) technology to prevent and resolve biofouling, scale, and microbial contamination in water and fluid systems while reducing reliance on conventional chemical treatment. The patent-pending CINB process replaces mechanical nanobubble generation with low-energy vapor-phase infusion, producing highly stable nanobubbles independently validated at UC Irvine, Cornell, and NJIT. It extends an intellectual property portfolio, granted and pending U.S. patents, the Mereduce™ biological platform, and decades of proprietary know-how. Its vapor infusion technologies have been in commercial service since 2014, including HTRI’s exclusive worldwide license covering heat exchangers and water processing. Additional exclusive licensees, including Solmetex and Roebic Laboratories, integrate I 2’s technologies into their own products and platforms, supported by organizations such as the U.S. Navy and USDA. Their technology focuses on using air‑fluid dynamics to improve safety, reduce fouling, and enhance system performance across diverse environments.